InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

MTW Insider Trading

Insider Ownership Percentage: 16.31%
Insider Buying (Last 12 Months): £3,634.02
Insider Selling (Last 12 Months): £38,782.64

Mattioli Woods Insider Trading History Chart

This chart shows the insider buying and selling history at Mattioli Woods by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mattioli Woods Share Price & Price History

Current Price: GBX 793
Price Change: ▲ Price Increase of +1 (0.13%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for MTW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Mattioli Woods Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2023Iain McKenzieInsiderSell6,068GBX 523£31,735.64
9/29/2023Ravi TaraInsiderSell1,215GBX 580£7,047
9/18/2023Edward KnappInsiderBuy6GBX 622GBX 3,732
5/9/2023Michael WrightInsiderBuy570GBX 631£3,596.70
3/6/2023Ian Thomas MattioliInsiderBuy25,000GBX 600£150,000
11/10/2022Ian Thomas MattioliInsiderBuy36,171GBX 548£198,217.08
10/10/2022Ian Thomas MattioliInsiderBuy572GBX 630£3,603.60
5/9/2022Ravi TaraInsiderBuy492GBX 730£3,591.60
4/1/2022Ian Thomas MattioliInsiderSell150,000GBX 780£1,170,000
2/10/2022Ian Thomas MattioliInsiderSell185,756GBX 800£1,486,048
1/7/2022Ian Thomas MattioliInsiderSell14,260GBX 851£121,352.60
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Mattioli Woods (LON:MTW)

72.44% of Mattioli Woods stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Mattioli Woods logo
Mattioli Woods plc provides wealth management and employee benefit services in the United Kingdom. It operates through five segments: Pension Consultancy and Administration, Investment and Asset Management, Private Equity Asset Management, Property Management, and Employee Benefits. The company offers self invested personal pension and small self-administered pension schemes; alternative investment and fund management; and employee engagement, defined contribution and defined benefit pension schemes, workplace savings, healthcare, international benefits, and risk solutions, as well as total reward and flexible benefit systems. The company offers its services to controlling directors and owner-managed businesses, professionals, executives, individuals, families, and retirees. Mattioli Woods plc was founded in 1991 and is based in Leicester, the United Kingdom.
Read More on Mattioli Woods

Today's Range

Now: GBX 793
Low: 790
High: 794

50 Day Range

MA: GBX 722.21
Low: 550
High: 798

52 Week Range

Now: GBX 793
Low: 481
High: 800

Volume

9,423 shs

Average Volume

317,656 shs

Market Capitalization

£411.88 million

P/E Ratio

4,173.68

Dividend Yield

3.41%

Beta

0.64

Who are the company insiders with the largest holdings of Mattioli Woods?

Mattioli Woods' top insider shareholders include:
  1. Edward Knapp (Insider)
  2. Iain McKenzie (Insider)
  3. Ian Thomas Mattioli (Insider)
  4. Michael Wright (Insider)
  5. Ravi Tara (Insider)
Learn More about top insider investors at Mattioli Woods.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...